Detalhe da pesquisa
1.
Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus.
Cell
; 176(6): 1420-1431.e17, 2019 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30849373
2.
Modulation of immune responses using adjuvants to facilitate therapeutic vaccination.
Immunol Rev
; 296(1): 169-190, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32594569
3.
Potential business model for a European vaccine R&D infrastructure and its estimated socio-economic impact.
F1000Res
; 12: 1401, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38298529
4.
Vaccine-Induced Th1-Type Response Protects against Invasive Group A Streptococcus Infection in the Absence of Opsonizing Antibodies.
mBio
; 11(2)2020 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32156809
5.
Comparative expression analysis and characterization of 20S proteasomes in human intestinal tissues: The proteasome pattern as diagnostic tool for IBD patients.
Inflamm Bowel Dis
; 15(4): 526-33, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19067411
6.
Quiescence and functional reprogramming of Epstein-Barr virus (EBV)-specific CD8+ T cells during persistent infection.
Blood
; 106(2): 558-65, 2005 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15797994